Abstract | INTRODUCTION: METHODS: This study was performed from July 2013 to July 2016 on 33 subjects. This is a double-blind, placebo-controlled, crossover trial injecting 80-120 units of IncoA into 8-14 hand and forearm muscles using a customized approach. The subjects were followed for 28 weeks. The treatment efficacy was evaluated by the Fahn Tolosa Marin tremor rating score and NIH genetic criteria for tremor severity at 4 and 8 weeks after each of the two sets of treatments. Hand strength was assessed by an ergometer. RESULTS: There was statistically significant improvement in clinical rating score of tremor at 4 and 8 weeks following the IncoA injection. CONCLUSION: In this study, injection of IncoA treatment via a customized approach improved essential tremor on the clinical scales and patient's perception with a low occurrence of significant hand weakness.
|
Authors | Shivam Om Mittal, Duarte Machado, Diana Richardson, Divyanshu Dubey, Bahman Jabbari |
Journal | Parkinsonism & related disorders
(Parkinsonism Relat Disord)
Vol. 56
Pg. 65-69
(11 2018)
ISSN: 1873-5126 [Electronic] England |
PMID | 29929813
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2018 Elsevier Ltd. All rights reserved. |
Chemical References |
- Neuromuscular Agents
- Botulinum Toxins, Type A
- incobotulinumtoxinA
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Botulinum Toxins, Type A
(administration & dosage)
- Cross-Over Studies
- Double-Blind Method
- Essential Tremor
(diagnosis, drug therapy, physiopathology)
- Female
- Hand
(innervation, physiopathology)
- Humans
- Male
- Middle Aged
- Neuromuscular Agents
(administration & dosage)
- Treatment Outcome
|